Media headlines about Aemetis (NASDAQ:AMTX) have been trending somewhat positive recently, Accern Sentiment Analysis reports. The research firm rates the sentiment of news coverage by reviewing more than twenty million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Aemetis earned a news sentiment score of 0.22 on Accern’s scale. Accern also gave news stories about the specialty chemicals company an impact score of 45.3730963834897 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.

Shares of Aemetis (NASDAQ AMTX) traded down 1.52% on Friday, reaching $0.85. 32,049 shares of the company’s stock traded hands. The firm’s market capitalization is $16.85 million. Aemetis has a 52 week low of $0.82 and a 52 week high of $2.50. The company’s 50-day moving average is $1.11 and its 200-day moving average is $1.24.

Several brokerages have weighed in on AMTX. FBR & Co reissued a “neutral” rating and set a $2.00 price objective on shares of Aemetis in a report on Saturday, August 19th. Zacks Investment Research raised shares of Aemetis from a “sell” rating to a “hold” rating in a report on Thursday, July 20th.

COPYRIGHT VIOLATION WARNING: “Aemetis (AMTX) Getting Somewhat Positive Press Coverage, Analysis Shows” was reported by Watch List News and is the property of of Watch List News. If you are reading this story on another publication, it was stolen and republished in violation of international copyright legislation. The correct version of this story can be viewed at

Aemetis Company Profile

Aemetis, Inc is an international renewable fuels and biochemicals company. The Company is focused on the production of fuels and chemicals through the acquisition, development and commercialization of technologies that replace traditional petroleum-based products by conversion of first-generation ethanol and biodiesel plants into biorefineries.

Insider Buying and Selling by Quarter for Aemetis (NASDAQ:AMTX)

Receive News & Ratings for Aemetis Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aemetis Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.